PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
72.38
ESG score 1.1-1.2x Healthcare median of 61.86. Philip Fisher would examine if superior ESG practices support long-term growth and stakeholder loyalty.
62.46
Environmental score 1.1-1.2x Healthcare median of 58.90. Philip Fisher would examine if superior environmental practices support long-term competitive positioning.
84.05
Social score exceeding 1.2x Healthcare median of 63.86. Joel Greenblatt would verify if this social leadership translates to employee productivity and customer loyalty advantages.
70.64
Governance score 1.1-1.2x Healthcare median of 63.47. Philip Fisher would examine if superior governance practices support long-term value creation.